These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38291601)

  • 1. Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.
    Roy DC; Wang TF; Lun R; Zahrai A; Mallick R; Burger D; Zitikyte G; Hawken S; Wells P
    Am J Hematol; 2024 Apr; 99(4):577-585. PubMed ID: 38291601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Roy DC; Wang TF; Carrier M; Mallick R; Burger D; Hawken S; Wells PS
    J Thromb Haemost; 2023 Nov; 21(11):3184-3192. PubMed ID: 37536569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
    J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
    Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
    Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
    Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Contribution of Inherited Thrombophilia to Venous Thromboembolism in Cancer Patients.
    Costa J; Araújo A
    Clin Appl Thromb Hemost; 2024; 30():10760296241232864. PubMed ID: 38442893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.
    Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
    Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review.
    Ho WK; Hankey GJ; Quinlan DJ; Eikelboom JW
    Arch Intern Med; 2006 Apr; 166(7):729-36. PubMed ID: 16606808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS; Miletich JP; Goldhaber SZ; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2001 Jan; 37(1):215-8. PubMed ID: 11153741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
    Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
    Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
    Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.